Accès ouvert
2025
article
OpenAlex
Oleg Mikhailovich Uryasev, A. V. Solovieva, Sergey B. Aksentyev, Denis S. Yunevich et autres
INTRODUCTION: Systemic thrombolysis is an effective and safe method of reperfusion therapy in ischemic stroke. However, the effectiveness and safety of different thrombolytic drugs are not the same. It is relevant to analyze the use of systemic thrombolytics in real clinical practice …
ru
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
В. А. Марков, Dmitry Viktorovich Duplyakov, S. L. Konstantinov, Gernot Klein et autres
Aim.To study the effectiveness of Fortelyzin® in subgroups with different body weights in patients with ST-segment elevation acute myocardial infarction (STEMI) in the FRIDOM1 study and real clinical practice. Material and methods.Fortelyzin® was administered in a single-bolus dose of 15 mg over …
ru, gb, us, kr
(code pays fourni par la source)
2022
article
OpenAlex
Evgeny I. Gusev, M. Yu. Martynov, Nikolay A Shamalov, Elena Borisovna Yarovaya et autres
ЦЕЛЬ ИССЛЕДОВАНИЯ Изучение эффективности и безопасности неиммуногенной стафилокиназы (НС) в сравнении с алтеплазой (А) у пациентов с ишемическим инсультом (ИИ) в первые 4,5 ч от развития симптомов. МАТЕРИАЛ И МЕТОДЫ В открытом рандомизированном сравнительном исследовании «не меньшей эффективности» в параллельных группах НС …
ru, us
(code pays fourni par la source)
2021
article
OpenAlex
Eugene I. Gusev, M. Yu. Martynov, Alexey A Nikonov, Nikolay A Shamalov et autres
ru
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
S. B. Aksentiev, A. V. Solovieva, Denis S. Yunevich
Aim. To compare the efficacy and safety of prasugrel, ticagrelor, or clopidogrel as part of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI) due to myocardial infarction (MI). Material and methods. The observational study included 74 patients who underwent …
ru
(code pays fourni par la source)
Accès ouvert
2018
article
OpenAlex
В. А. Марков, Dmitry Viktorovich Duplyakov, S. L. Konstantinov, Gernot Klein et autres
Aim. Evaluate the oneyear results and clinical outcomes of a multicenter randomized clinical trial FRIDOM1. Material and methods. The study FRIDOM1 was conducted in 11 clinical centers of the Russian Federation in the period 20142016. The study included 382 patients with acute …
ru
(code pays fourni par la source)
Accès ouvert
2018
article
OpenAlex
Denis S. Yunevich, S. B. Aksentiev
The article presents two clinical cases of successful reuse thrombolytic drug Fortelyzin® in the total dose of 25-30 mg observed by the authors in patients with acute coronary syndrome with ST-segment elevation, treated in the urgent cardiology department of the State budget …
Accès ouvert
2016
article
OpenAlex
Denis S. Yunevich
The results present the comparative analysis of the efficacy and safety of thrombolytic therapy with different drugs in 98 patients 75 years and older with myocardial infarction with ST-segment elevation. The prevalence of 28-day mortality was observed after the introduction of streptokinase …
ru
(code pays fourni par la source)
Accès ouvert
2015
article
OpenAlex
Samar Bellil, S. S. Yаkushin, С Б Аксентьев, Denis S. Yunevich
In this article we studied the prognosis of various schemes of reperfusion therapy and subsequent medical treatment during a year of observation in elderly and senile patients with ST elevation myocardial infarction. We examined 80 patients, 46 of them were elderly, and …
Accès ouvert
2014
article
OpenAlex
Denis S. Yunevich, S. B. Aksentiev, Л В Денискина, О В Фокина et autres
The results present the research of parameters of the efficacy and safety of thrombolytic therapy (TLT) actilyse in 95 patients with myocardial infarction, depending on age. Observed increase in 28-day mortality and incidence of undesirable effects in individuals TLT older age groups. …